Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03724110 · ClinicalTrials.gov registry record
Telestroke for Comprehensive Transient Ischemic Attack Care in Acute Stroke Ready Hospitals
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 300
- Enrollment target
NCT03724110 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 300 participants.
The verdict
NCT03724110 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
Study Summary
TELECAST-TIA is a prospective single-center study evaluating guideline-based transient ischemic attack (TIA) treatment at an Acute Stroke Ready Hospital (ASRH) pre- and post-initiation of a specialist telestroke inpatient rounding service. TELECAST-TIA will study the following clinical endpoints: diagnostic stroke evaluation, secondary stroke prevention, health screening and evaluation, stroke education, inpatient complications, and stroke recurrence rates. Additional relevant non-clinical data will include patient and provider satisfaction scores, transfer patterns, and a cost analysis.
Interventions
- OTHER Telestroke
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2018-10-02 |
| Est. Completion | 2022-07-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03724110
The ClinicalTrials.gov registry entry for NCT03724110 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Telestroke is the first listed.
NCT03724110 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03724110 about?
NCT03724110 is a clinical study titled "Telestroke for Comprehensive Transient Ischemic Attack Care in Acute Stroke Ready Hospitals". TELECAST-TIA is a prospective single-center study evaluating guideline-based transient ischemic attack (TIA) treatment at an Acute Stroke Ready Hospital (ASRH) pre- and post-initiation of a specialist telestroke inpatient rounding service. TELECAST-TIA will study the following clinical endpoints: di...
What is the current status of trial NCT03724110?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2018-10-02. Estimated completion is 2022-07-02.
What interventions are being tested in trial NCT03724110?
The interventions under investigation include: Telestroke (OTHER).
Who is sponsoring clinical trial NCT03724110?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.